Embody, Inc.

Embody, Inc. is a soft tissue healing company specializing in biointegrative orthopedic solutions for tendon and ligament repair. Founded in 2014 with initial DARPA funding of $11.85 million, the company develops collagen-based biointegrative implants designed to support healing in challenging soft tissue injuries. The company's flagship product platform, TAPESTRY, is a biointegrative implant that promotes dense, collagenous tissue ingrowth to facilitate tendon and ligament healing. TAPESTRY RC, launched in 2020, is an arthroscopic delivery and fixation system that enables minimally invasive deployment of the TAPESTRY implant. Clinical applications include rotator cuff repair (addressing the 800,000+ annual US procedures), Achilles tendon repair, knee ligament repair (500,000+ annual procedures), and foot and ankle soft tissue procedures (400,000+ annual procedures). The implants are designed to create an optimal microenvironment for tissue regeneration and integration. Embody was acquired by Zimmer Biomet in January 2023, integrating its soft tissue healing technology into a major orthopedic medical device portfolio. The company manufactures biointegrative medical devices with regulatory pathways typical of orthopedic implants and surgical delivery systems.